Search Results 131-140 of 2286 for 구글찌라시 つ 13242130 つ텔@adtopkingつつ구글콘솔つつつ텔@adtopkingつつつ구글찌라시つつつ
Necuparanib has been re-engineered from heparin to have much lower blood thinning activity while keeping the anti-tumor activity. The investigators are testing ...
EPCAM. MLH1. MSH2. MSH6. STK11. PMS2. For participants with monogenic risk, the GIRA report recommends referral to a genetic counselor.
The purpose of this study is to evaluate the effectiveness and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) ...
Research activities within the Department of Molecular Pharmacology and Experimental Therapeutics are affiliated with several other Mayo Clinic research areas:.
About this study. The purpose of this study is to evaluate the safety and effectiveness of the MicroVention Flow Redirection Intraluminal Device (FRED) ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to ...
The purpose of this study is to determine if lenalidomide (Revlimid®) is safe and effective as a maintenance therapy at improving further the quality of the ...
Recent developments in genetic and molecular biology research provide opportunities to investigate the molecular events of tendon healing. TGF-beta regulates ...
After completing standard-of-care (SOC) CDI antibiotics for their most recent CDI recurrence, patients who meet all eligibility requirements will be randomized ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift that can go twice as far to advance healthcare research.